Citation Impact
Citing Papers
The principal results of the International Immune Tolerance Study: a randomized dose comparison
2011
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
2009 Standout
Platelet thrombin receptor antagonism and atherothrombosis
2009
The P2X1 receptor and platelet function
2011
The efficacy and value of emergency medicine: a supportive literature review
2011 Standout
Parenteral Anticoagulants
2012 Standout
Improvements in Factor VIII Inhibitor Detection: From Bethesda to Nijmegen
2009
Signals from the lysosome: a control centre for cellular clearance and energy metabolism
2013 Standout
Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven®] in elective orthopaedic surgery in haemophilic patients with inhibitors
2009
8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer
2008 Standout
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Haemostatic materials for wound healing applications
2021 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence
2009
Thromboembolism in pregnancy: recurrence risks, prevention and management
2008
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury
2014
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation
2006
Therapeutic applications of compounds in the Magnolia family
2011 Standout
Guidelines on the investigation and management of antiphospholipid syndrome
2012
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
International workshop on immune tolerance induction: consensus recommendations1
2007
Antithrombotic Therapy for VTE Disease
2016 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence‐based approaches
2010
Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces
2009
Prevention of VTE in Nonsurgical Patients
2012 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets
2012 StandoutNobel
Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy
2008
Abbreviated Educational Session Improves Cranial Computed Tomography Scan Interpretations by Emergency Physicians
1997
A Microhomology-Mediated Break-Induced Replication Model for the Origin of Human Copy Number Variation
2009
Executive Summary
2012 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas
2002
Targeting apoptosis in cancer therapy
2020 Standout
Radiographic interpretation in the emergency department
1996
Assessing the quality of controlled clinical trials
2001 Standout
Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review
2005
Immune tolerance induction in haemophilia: evidence and the way forward
2011
The Rate of Clinically Significant Plain Radiograph Misinterpretation by Faculty in an Emergency Medicine Residency Program
1996
The creation of an antithrombotic surface by apyrase immobilization
2010 StandoutNobel
Interplay between platelets and coagulation
2020
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
2012
Reducing errors made by emergency physicians in interpreting radiographs: longitudinal study
2000
Colorectal cancer chemotherapy
2003
Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care
2008
Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma
2000
Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data
2008
Pediatric Emergency Physician Interpretation of Plain Radiographs: Is Routine Review by a Radiologist Necessary and Cost-Effective?
1996
The platelet release reaction: just when you thought platelet secretion was simple
2008
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807)
2003
Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups
2006 Standout
Second-Line Treatment of Advanced Gastric Cancer with Oxaliplatin plus Raltitrexed
2003
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Secretable Human Platelet-Derived Factor V Originates From the Plasma Pool
1998
Tumour stem cells and drug resistance
2005 Standout
Is the NHS equitable?: a review of the evidence
2003
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
2011 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial
2005 Standout
Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of α1-antitrypsin
2011 StandoutNobel
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
2014 Standout
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
2003 Standout
How I treat age-related morbidities in elderly persons with hemophilia
2009
Venous Thromboembolism in Pregnancy
2009
Secretable Human Platelet-Derived Factor V Originates From the Plasma Pool
1998
The regulation of platelet-dense granules by Rab27a in the ashen mouse, a model of Hermansky-Pudlak and Griscelli syndromes, is granule-specific and dependent on genetic background
2002
Cellular and molecular pharmacology of oxaliplatin.
2002
Chemotherapy for advanced gastric cancer
2017 Standout
Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation–associated thrombotic microangiopathy
2011
The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway
2010 Standout
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Targeting the Apoptosome for Cancer Therapy
2009
Receptors for Purines and Pyrimidines
2012 Standout
Hematopoietic stem cell transplant–associated thrombotic microangiopathy: review of pharmacologic treatment options
2014
Impact of treatment and outcomes for patients with posttransplant drug‐associated thrombotic microangiopathy
2017
Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.
2002
Rab27a is a key component of the secretory machinery of azurophilic granules in granulocytes
2007 StandoutNobel
Guidelines for the management of hemophilia
2012 Standout
Hematological Problems in Pediatric Intensive Care
2013 Standout
Works of Mark P. Smith being referenced
Immune Tolerance Therapy for Haemophilia
2000
Real‐Time quantitative PCR analysis of factor XI mRNA variants in human platelets
2004
7 Megakaryocytes and platelets in α-granule disorders
1997
Physician assessments of practice patterns in emergency department radiograph interpretation
1988
Variations in use of tertiary cardiac services in part of North-West England
2002
A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation
2003
Double complex mutations involvingF8andFUNDC2caused by distinct break-induced replication
2007
The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants
2003
Recombinant factor VIIa as an adjunctive therapy for patients requiring large volume transfusion: a pharmacoeconomic evaluation
2005
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia
2008
Phase II study of raltitrexed (‘Tomudex’) for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens
1999
Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy
2004
Evidence for a role for Gαi1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Gαi1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder
2003
Acquired haemophilia A
1998
Raltitrexed (‘Tomudex’) and oxaliplatin: an active out-patient regimen in malignant mesothelioma
1999
Successful Treatment of Transplant Associated Microangiopathy with Rituximab
2008
Rapid Genetic Diagnosis in Neonatal Pulmonary Artery Thrombosis Caused by Homozygous Antithrombin Budapest 3
2000
Phase I, Dose-Finding, and Pharmacokinetic Study of Raltitrexed Combined With Oxaliplatin in Patients With Advanced Cancer
2000
Immune Tolerance Therapy for Haemophilia A Patients with Acquired Factor VIII Alloantibodies: Comprehensive Analysis of Experience at a Single Institution
1999
Qualitative and chronological assessment of toxicities during treatment with raltitrexed (‘Tomudex’) in 861 patients: implications for patient management
1999
Tinzaparin sodium for thrombosis treatment and prevention during pregnancy
2004
Elective Surgery on Factor VIII Inhibitor Patients Using Continuous Infusion of Recombinant Activated Factor VII
2001